Purpose To investigate the effect of 0.01% carbachol on early intraocular pressure (lOP) after cataract extraction with phacoemulsification.
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Materials and methods
Fifty-one patients undergoing phacoemulsification and IOL implantation were prospectively randomly assigned to one of two groups. The treatment group (n = 27) received 0.5 ml carbachol 0.01% intracamerally and the control group (n = 24) received 0. 
Results
The mean lOPs were not significantly different between the two groups pre-operatively (p > 0.5) ( Table 1) .
However, for each of the post-operative measurements the mean lOP in the carbachol group was lower than the control group mean value. Mean post-operative lOP values in the carbachol group remained below the pre operative baseline value throughout the study period, whereas only the 7 day mean lOP value in the control group was lower than baseline. suggested the use of a lower dose of carbachol for prevention of brow ache after surgery.
The pre-, per-and post-operative management as well as the testing of patients were made as identical as possible in the current study. Because all 51 patients in our study received the same amount of the same viscoelastic, this factor cannot contribute to the differences we found. In addition, the viscoelastic agent was aspirated carefully not only from the anterior chamber but also from the capsular bag behind the IOL just before the injection of carbachol.
Influence of surgical technique on the increase in lOP after cataract surgery has been knownY As it minimises possible trauma to the angle structures because of the small incision used,18 phacoemulsification causes less lOP elevation than extracapsular cataract extraction.13
Mean lOP in the control group was highest at 8 h post operatively in the control group. It then began to decrease to a mean lower than its pre-operative value and similar to the value in the carbachol group.
In conclusion, carbachol used for intraoperative miosis significantly reduces post-operative lOP increases to a minimum. It can be used safely in clear corneal phacoemulsification surgery with posterior chamber IOL implantation.
